Sandoz Group (OTCMKTS:SDZNY) Trading Up 0.8% – Should You Buy?

Sandoz Group AG (OTCMKTS:SDZNY) was up 0.8% during trading on Monday . The company traded as high as $45.85 and last traded at $45.69. Approximately 25,020 shares changed hands during mid-day trading, a decline of 74% from the average daily volume of 97,949 shares. The stock had previously closed at $45.32.

Analyst Ratings Changes

Separately, Royal Bank of Canada lowered Sandoz Group from a “moderate buy” rating to a “hold” rating in a research report on Monday, September 16th.

Sandoz Group Stock Performance

The company has a 50 day moving average price of $43.54 and a 200-day moving average price of $40.42.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.